The positive investor response follows the publication of an order that is viewed as a largely symbolic reaction to Congressional Republicans' decision not to include any new pharmaceutical pricing legislation in the Budget Reconciliation Bill.
Pharma stocks rise in response to Trump's 'MFN' executive order
May 12, 2025 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Radiopharm Theranostics reports Preclinical Lu177-B7H3-mAb data
June 2, 2025 - - Australian Biotech -
Neurotech announces positive human PK study results for NTI164
June 2, 2025 - - Australian Biotech -
Cardiex receives TGA approval for CONNEQT Pulse arterial health monitor
June 2, 2025 - - Australian Biotech -
Pharmac minister sworn in as New Zealand's Deputy Prime Minister
June 1, 2025 - - Latest News -
An opportunity for reflection on the need to humanise PBS decision-making
June 1, 2025 - - Latest News -
Ipsen's Julien Dagher promoted to European leadership role
June 1, 2025 - - Latest News -
Daiichi Sankyo secures certification as Great Place to Work
June 1, 2025 - - Latest News